<DOC>
	<DOCNO>NCT00933348</DOCNO>
	<brief_summary>The purpose study examine safety efficacy fruit-based product OPAL A treatment chronic venous pressure ulcer .</brief_summary>
	<brief_title>Safety Efficacy Fruit-based Product OPAL A Treatment Chronic Venous Pressure Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Male female . Aged ≥ 18 year . Presence either : venous leg ulcer surface area ≥ 2 cm2 &lt; 25 cm2 ( best estimate debrided wound ) , OR Stage II III pressure ulcer ( per Australian Wound Management Association [ AWMA ] definition ) Able tolerate compression therapy ( venous ulcer group ) Willing able provide write informed consent Additional inclusion criterion fourweek standard care runin period : le equal 25 % reduction wound surface area compare wound surface area screen visit Another ulcer within 10 cm ulcer treat Patients diabetes ( fast blood glucose value ≥ 7 mmol/L random blood glucose &gt; 11 mmol/L ) opinion investigator uncontrolled Anklebrachial pressure index &lt; 0.8 ( participant venous ulcer ) Alanine transaminase ( ALT ) aspartate transaminase ( AST ) level 3X upper limit normal Any dermatologic condition disorder ( exception dermatitis associate venous stasis ) may interfere appropriate assessment treatment participant 's ulcer Clinical sign ulcer infection . Current recent ( within past two week ) daily treatment immunosuppressive medication ( include oral corticosteroid ; inhale topical corticosteroid permit ; topical agent must apply within 10 cm ulcer wound ) , cytotoxins antiinflammatory agent ( intermittent nonsteroidal antiinflammatory agent use permit ) Known hypersensitivity paw paw product Pregnancy , plan pregnancy lactation Participation another clinical trial within one month study entry Another disease condition opinion investigator may jeopardize safety participant ability participate study Participant previously screen randomize study Cognitive impairment opinion investigator leave participant incapable providing informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>ulcer</keyword>
	<keyword>venous</keyword>
	<keyword>pressure</keyword>
	<keyword>wound</keyword>
	<keyword>treatment</keyword>
</DOC>